Caristo Diagnostics launched to commercialise new coronary CT image analysis technology
Caristo Diagnostics, an Oxford University spinout company, has been launched to commercialise a new coronary CT image analysis technology that can identify patients at...
Rivaroxaban gets FDA approval for treatment in CAD or PAD
Rivaroxaban, brand name Xarelto (Janssen), has received approval by the US Food and Drug Administration (FDA) to reduce the risk of major cardiovascular (CV)...
TMVI with Tiara valve may be safe and feasible for patients with prior aortic...
A new study indicates that transcatheter mitral valve implantation (TMVI) with the Tiara valve (Neovasc) can be safely and successfully implanted in patients with...
Risk of death with unrecognised myocardial infarction equal to that with recognised myocardial infarction...
Tushar Acharya (National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, USA) and others report in JAMA Cardiology that within 10 years,...
(Visited 12,718 times, 22 visits today)
